Our Pricing

Start NHS-Approved Weight Loss Injections Today

Looking for NHS-approved weight loss injections UK options through a trusted online pharmacy? Cured Pharmacy offers genuine MHRA-licensed treatments including Mounjaro, Wegovy, and Saxenda, all dispensed following clinical assessment by UK-registered prescribers. Our transparent pricing starts from £135.00 with free consultations completed in under three minutes and discreet next-day delivery across the UK.

What Are NHS-Approved Weight Loss Injections?

NHS-approved weight loss injections are prescription medications licensed by the Medicines and Healthcare products Regulatory Agency (MHRA) for weight management in adults with a BMI of 30 or above, or 27 with weight-related health conditions [1]. These treatments work by mimicking natural hormones called incretins, which regulate appetite, blood sugar levels, and how your body processes food.

The most commonly prescribed injections belong to a class called GLP-1 receptor agonists, which include semaglutide (Wegovy) and liraglutide (Saxenda). The newest treatment, tirzepatide (Mounjaro), is a dual GIP/GLP-1 receptor agonist that activates two hormone pathways simultaneously, producing enhanced clinical effects [2]. In the SURPASS-3 trial, participants using the highest dose of tirzepatide achieved an average body weight reduction of 22.5% over 72 weeks, compared to 6.2% with placebo [2].

All prescription weight loss injections available through Cured Pharmacy require a clinical assessment by a UK-registered prescriber. This ensures the treatment is medically appropriate for your individual health profile, current medications, and weight loss goals. Our superintendent pharmacist, Tarun Kumar (GPhC 2233073), oversees every prescription to ensure patient safety and regulatory compliance.

How GLP-1 Weight Loss Injections Work

Clinical trials consistently demonstrate that GLP-1 treatments produce substantially greater weight loss than lifestyle changes alone. In the STEP 1 trial, adults using semaglutide 2.4mg (Wegovy) lost an average of 14.9% of their body weight over 68 weeks, compared to 2.4% in the placebo group [4]. Importantly, 86.4% of participants in the semaglutide group achieved at least 5% weight loss, which is the threshold associated with meaningful improvements in cardiovascular risk factors.

The effectiveness of these treatments depends on consistent weekly injections combined with a reduced-calorie diet and increased physical activity. They are not standalone solutions but powerful tools that make sustainable lifestyle changes significantly more achievable by reducing the physiological drive to overeat.

The Science Behind Appetite Regulation

GLP-1 (glucagon-like peptide-1) is a hormone naturally produced in your intestines after eating. It signals to your brain that you're full, slows down how quickly food leaves your stomach, and helps regulate blood sugar levels. Weight loss injections contain synthetic versions of this hormone that last much longer in your body than the natural version, providing sustained appetite control throughout the week [3].

When you inject these medications subcutaneously (under the skin), they bind to GLP-1 receptors in multiple organs including the brain, pancreas, and stomach. This triggers a cascade of effects: reduced hunger signals, increased feelings of fullness after smaller meals, slower gastric emptying, and improved insulin sensitivity. The result is a significant reduction in calorie intake without the constant hunger that typically accompanies traditional dieting [3].

Mounjaro vs Wegovy vs Saxenda: Comparing Your Options

Your choice between these treatments depends on several factors including your weight loss goals, injection frequency preference, side effect tolerance, and budget. Mounjaro typically produces the greatest weight reduction but requires careful dose escalation to minimise gastrointestinal side effects. Wegovy offers a balance of efficacy and once-weekly convenience, whilst Saxenda's daily dosing allows more gradual dose adjustments for patients who are particularly sensitive to side effects.

During your free online consultation at Cured Pharmacy, a UK prescriber will review your medical history, current medications, previous weight loss attempts, and any contraindications to recommend the most appropriate treatment. All three medications require subcutaneous injection, typically into the abdomen, thigh, or upper arm, using pre-filled pens designed for home use.

Mechanism and Efficacy Differences

Mounjaro (tirzepatide) represents the latest advancement in weight loss pharmacotherapy as the first dual GIP/GLP-1 receptor agonist licensed in the UK. By activating both glucose-dependent insulinotropic polypeptide (GIP) and GLP-1 receptors, it produces greater weight loss than single-pathway treatments in head-to-head trials [2]. The SURPASS-2 study showed tirzepatide 15mg resulted in 12.4kg greater weight loss than semaglutide 1mg over 40 weeks.

Wegovy (semaglutide) is a once-weekly GLP-1 receptor agonist that has become a cornerstone of medical weight management since its UK approval. It's administered at a higher dose (2.4mg) than the same medication used for diabetes (Ozempic, up to 1mg), specifically optimised for weight loss. Saxenda (liraglutide) is a daily injection that was the first GLP-1 treatment licensed specifically for weight management in the UK, offering an established safety profile with over a decade of clinical use [1][4].

Starting Weight Loss Injections: What to Expect

Weight loss with these injections is typically gradual but consistent. Most patients notice reduced appetite within the first week, with measurable weight loss becoming apparent by weeks 4-8. The most substantial weight reduction usually occurs between months 3-9 of treatment, with results plateauing as you approach your new set point [3]. Clinical trials show that continuing treatment maintains weight loss, whilst discontinuation often leads to gradual weight regain.

Throughout your treatment journey, you'll need to maintain regular contact with your prescriber for monitoring and prescription renewals. At Cured Pharmacy, follow-up consultations ensure your treatment remains appropriate, doses are optimised, and any concerns are addressed promptly. We recommend combining your injections with a structured nutrition plan and regular physical activity for optimal results, as clinical trial participants who made lifestyle changes achieved significantly greater weight loss than those relying on medication alone.

The Dose Escalation Process

All GLP-1 and dual GIP/GLP-1 treatments follow a gradual dose escalation schedule to minimise side effects, particularly nausea. You'll start on the lowest dose for 4 weeks, then increase every 4 weeks until you reach your maintenance dose or the highest dose you can tolerate comfortably. For Wegovy, this means starting at 0.25mg weekly and potentially reaching 2.4mg by week 17. Mounjaro begins at 2.5mg weekly, with possible escalation to 15mg [2][4].

This titration period allows your body to adapt to the medication's effects on gastric emptying and appetite signals. Most patients experience the most noticeable side effects during the first few weeks after each dose increase, which then typically subside as your system adjusts. Your prescriber may recommend staying at a lower dose longer if you're experiencing persistent side effects or achieving your weight loss goals at that level.

Common Side Effects and How to Manage Them

Gastrointestinal side effects are the most frequently reported with GLP-1 weight loss injections, affecting up to 44% of patients in clinical trials [4]. Nausea is the most common, followed by diarrhoea, constipation, vomiting, and abdominal discomfort. These effects typically occur during the first few weeks of treatment or after dose increases, and usually diminish over time as your body adapts to slower gastric emptying.

To minimise nausea, eat smaller, more frequent meals rather than large portions, avoid high-fat and spicy foods, stay well-hydrated, and inject your medication at a time when you can rest if needed. If you experience vomiting, ensure you're replacing fluids to prevent dehydration. Persistent or severe gastrointestinal symptoms should be reported to your prescriber, who may recommend staying at your current dose longer before escalating, or adjusting your treatment plan.

Less common but more serious side effects include pancreatitis (inflammation of the pancreas), gallbladder problems, and changes in vision for patients with pre-existing diabetic retinopathy. These medications also carry a boxed warning about thyroid C-cell tumours observed in animal studies, though no causal relationship has been established in humans [1][2]. Your prescriber will screen for contraindications during your consultation, including personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2.

Injection site reactions such as redness, itching, or mild swelling affect approximately 2-5% of patients but are usually mild and resolve quickly. Rotate your injection sites with each dose to reduce this risk. If you develop signs of an allergic reaction including severe rash, difficulty breathing, or facial swelling, seek immediate medical attention and discontinue the medication.

Getting Started with Cured Pharmacy

We stock genuine UK-licensed medications only, sourced directly from licensed wholesalers and manufacturers. Every prescription is checked by our superintendent pharmacist, Tarun Kumar (GPhC 2233073), ensuring accuracy and patient safety. Your medication arrives with full patient information leaflets, injection instructions, and sharps disposal guidance.

Ongoing support is included throughout your treatment. You can contact our clinical team with questions, request dose adjustments, or arrange follow-up consultations as needed. We also provide prescription reminders so you never run out of medication, maintaining consistency in your weight loss journey. If you experience side effects or have concerns between consultations, our team is available by phone on (+44) 116 4646009 during business hours.

Our Clinical Assessment Process

Starting your weight loss injection treatment with Cured Pharmacy begins with a comprehensive online consultation that takes under three minutes to complete. You'll answer questions about your current weight and height, medical history, current medications, previous weight loss attempts, and any contraindications to GLP-1 treatments. This information is reviewed by a UK-registered prescriber who determines whether treatment is clinically appropriate for you.

Unlike some online services that show prices only after consultation, Cured Pharmacy displays transparent upfront pricing so you know exactly what to expect. Our prices are among the most competitive in the UK market, with no hidden fees or subscription traps. If your prescriber approves treatment, your medication is dispensed by our GPhC-registered pharmacy (9012511) and dispatched in 100% discreet packaging via next-day delivery to any UK address.

Scientific References

1. Pi-Sunyer, X., et al. (2015). A Randomized, Controlled Trial of 3.0 mg of Liraglutide in Weight Management. New England Journal of Medicine, 373(1), 11–22. https://doi.org/10.1056/NEJMoa1411892
2. Jastreboff, A. M., et al. (2022). Tirzepatide Once Weekly for the Treatment of Obesity. New England Journal of Medicine, 387(3), 205–216. https://doi.org/10.1056/NEJMoa2206038
3. Müller, T. D., et al. (2019). Glucagon-like peptide 1 (GLP-1). Molecular Metabolism, 30, 72–130. https://doi.org/10.1016/j.molmet.2019.09.010
4. Wilding, J. P. H., et al. (2021). Once-Weekly Semaglutide in Adults with Overweight or Obesity. New England Journal of Medicine, 384(11), 989–1002. https://doi.org/10.1056/NEJMoa2032183

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication. Weight loss results vary between individuals and depend on multiple factors including adherence to treatment, lifestyle modifications, and individual metabolic responses.